Cargando…

Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study

INTRODUCTION: The aim of this study was to investigate patient reported outcomes (PROs) of functional ability and health related quality of life (HRQoL) in patients with early (rheumatoid) arthritis during one year of remission steered treatment. METHODS: In this study, 610 patients with early rheum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heimans, Lotte, Boer, Kirsten VC Wevers-de, Koudijs, KK Michel, Visser, Karen, Goekoop-Ruiterman, Yvonne P, Harbers, Joop B, Steup-Beekman, Gerda M, Lard, Leroy R, Grillet, Bernard AM, Huizinga, Tom WJ, Allaart, Cornelia F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978457/ https://www.ncbi.nlm.nih.gov/pubmed/24517212 http://dx.doi.org/10.1186/ar4361

Ejemplares similares

Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study
por: Akdemir, Gülşah, et al.
Publicado: (2016)

Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study)
por: Heimans, Lotte, et al.
Publicado: (2016)

Rheumatologists’ adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission
por: Akdemir, G., et al.
Publicado: (2016)

Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives
por: Magro-Checa, César, et al.
Publicado: (2016)

Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus
por: Steens, Stefan CA, et al.
Publicado: (2006)

Dissociation in SLE: A part of lupus fog?
por: Monahan, Rory C, et al.
Publicado: (2021)

Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?
por: Bergstra, Sytske Anne, et al.
Publicado: (2020)

Laboratory and Neuroimaging Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: Where Do We Stand, Where To Go?
por: Magro-Checa, César, et al.
Publicado: (2018)

Effectiveness of four dynamic treatment strategies in patients with anticitrullinated protein antibody-negative rheumatoid arthritis: a randomised trial
por: Akdemir, G, et al.
Publicado: (2016)

White matter hyperintensities associate with cognitive slowing in patients with systemic lupus erythematosus and neuropsychiatric symptoms
por: Monahan, Rory Caitlin, et al.
Publicado: (2021)

Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis
por: Güler-Yüksel, Melek, et al.
Publicado: (2010)

DAS steered therapy in clinical practice; cross-sectional results from the METEOR database
por: Gvozdenović, Emilia, et al.
Publicado: (2016)

Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment
por: Heckert, Sascha L, et al.
Publicado: (2023)

Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in routine care
por: Burgers, L. E., et al.
Publicado: (2019)

To treat or not to treat with immunosuppressive therapy: psychiatric disorders in patients with systemic lupus erythematosus
por: Monahan, Rory C, et al.
Publicado: (2022)

Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis
por: Akdemir, Gülşah, et al.
Publicado: (2018)

Selective Involvement of the Amygdala in Systemic Lupus Erythematosus
por: Emmer, Bart J, et al.
Publicado: (2006)

Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activity
por: Monahan, Rory C, et al.
Publicado: (2021)

An Increase of the Character Function of Self-Directedness Is Centrally Involved in Symptom Reduction during Remission from Major Depression
por: Goekoop, Jaap G., et al.
Publicado: (2011)

Neuropsychiatric systemic lupus erythematosus is associated with a distinct type and shape of cerebral white matter hyperintensities
por: Inglese, Francesca, et al.
Publicado: (2021)

MRI-Based Classification of Neuropsychiatric Systemic Lupus Erythematosus Patients With Self-Supervised Contrastive Learning
por: Inglese, Francesca, et al.
Publicado: (2022)

Elevated IL-16 level is a non-genetic characteristic of patients with severe systemic lupus erythematosus
por: Lard, LR, et al.
Publicado: (2001)

Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations
por: Monahan, Rory C, et al.
Publicado: (2022)

C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus
por: van Schaarenburg, Rosanne A., et al.
Publicado: (2016)

Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis
por: Dirven, Linda, et al.
Publicado: (2012)

Pro-MMP levels and severity of RA
por: Tchetverikov, I, et al.
Publicado: (2003)

Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2006)

Performance of the proposed ACR–EULAR classification criteria for systemic lupus erythematosus (SLE) in a cohort of patients with SLE with neuropsychiatric symptoms
por: Gegenava, Maka, et al.
Publicado: (2019)

Different phenotypes of neuropsychiatric systemic lupus erythematosus are related to a distinct pattern of structural changes on brain MRI
por: Inglese, Francesca, et al.
Publicado: (2021)

Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply
por: Markusse, Iris M., et al.
Publicado: (2015)

Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations
por: Ajeganova, Sofia, et al.
Publicado: (2017)

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response
por: de Moel, Emma C., et al.
Publicado: (2019)

Longitudinal changes in cerebral white matter microstructure in newly diagnosed systemic lupus erythematosus patients
por: Silvagni, Ettore, et al.
Publicado: (2020)

A single nucleotide polymorphism on the IL-10 locus defines an expression polymorphism and a possible risk factor to develop RA
por: Lard, LR, et al.
Publicado: (2001)

TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol
por: Niemantsverdriet, Ellis, et al.
Publicado: (2020)

Steering Witness and Steering Criterion of Gaussian States
por: Ma, Ruifen, et al.
Publicado: (2021)

Quantitative susceptibility mapping in the thalamus and basal ganglia of systemic lupus erythematosus patients with neuropsychiatric complaints
por: Bulk, Marjolein, et al.
Publicado: (2021)

Suspected Transverse Myelitis with Normal MRI and CSF Findings in a Patient with Lupus: What to Do? A Case Series and Systematic Review
por: Monahan, Rory C, et al.
Publicado: (2020)

Tract-based white matter hyperintensity patterns in patients with systemic lupus erythematosus using an unsupervised machine learning approach
por: Rumetshofer, Theodor, et al.
Publicado: (2022)

Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis
por: Amkreutz, Josephine A. M. P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1arbqdjfaab6rtmhpfqb0nreqm